INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,632 | -23.8% | 31,334 | -7.4% | 0.01% | -28.6% |
Q2 2023 | $2,143 | +44.1% | 33,844 | +23.3% | 0.01% | +40.0% |
Q1 2023 | $1,487 | +2.3% | 27,459 | +0.0% | 0.01% | 0.0% |
Q4 2022 | $1,453 | -99.9% | 27,448 | +30.7% | 0.01% | +25.0% |
Q3 2022 | $977,000 | -9.5% | 21,006 | +11.1% | 0.00% | -20.0% |
Q2 2022 | $1,079,000 | -3.0% | 18,907 | +4.1% | 0.01% | +25.0% |
Q1 2022 | $1,112,000 | +100.4% | 18,165 | +71.3% | 0.00% | +100.0% |
Q4 2021 | $555,000 | +62.3% | 10,607 | -1.4% | 0.00% | 0.0% |
Q4 2020 | $342,000 | – | 10,758 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |